Waterfall plot by NHL subtype of change in target lesions. Quantitative target lesion assessment was not available for 24 evaluable patients. These included 20 patients with progressive disease based solely on clinical symptoms and 4 patients with stable disease who remained on study >1 cycle without evidence of disease progression before withdrawing consent. Black diagonal lines indicate PET-CT–confirmed CR. MCL, mantle cell lymphoma.